Skip to main content
. 2017 May 4;8(39):64853–64866. doi: 10.18632/oncotarget.17614

Figure 7. CB2 agonist enhanced the production of paracrine growth factors and inhibited profibrotic cytokines in AD-MSCs.

Figure 7

(A-F) Paracrine growth factors including VEGF, bFGF, HGF, and IGF-1 as well as profibrotic cytokines including PDGF andTGFβ were examined by respective ELISA kits. *P<0.05 between indicated groups..